Skip to content

English

Facebook LinkedIn YouTube

Search for:

HOME
PRODUCTS
- LABS | HOSPITALS | DOCTORS
  BSX READER
  BACTERIOLOGY
  PARASITOLOGY
  MYCOLOGY
  VIROLOGY
  COVID-19
  BIOCHEMISTRY
  WOMEN’S HEALTH
  INSTRUMENTS
- PHARMACY | GPO | DISTRIBUTION | RETAIL
  SELF-TESTS
  SELF-MEASUREMENT
  MEDICAL AIDS
  ORAL CARE
  THERMOTHERAPY
COMPANY
R&D
CONTACT
NEWS

Search for:

View Larger Image

AIDS 2018 (23 to 27 july 2018) // Amsterdam

Meet the Biosynex team at AIDS 2018

admintest2018-04-26T09:36:49+02:00April 25th, 2018|News|

Recent

Biosynex acquires Avalun to become European leader in rapid diagnostic testing
May 27th, 2021
Biosynex announces that it has signed a binding offer to acquire 100% shares of the Avalun
April 15th, 2021
ICASA 2019 : Inside the Community Village
December 6th, 2019

Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (RDTs) in France and internationally. The RDTs, in their professional version, allow a better medical management of the patients thanks to the speed of their result and their simplicity of use. In their self-test version, they allow the general public self-monitoring of various pathologies thus ensuring better prevention and accelerating the demand for care.

BIOSYNEX COMPANY

Home
About us
Results
PHARMACY | RETAIL
LABORATORIES | HOSPITALS
News
Carriers
Contact

NEWS

Biosynex acquires Avalun to become European leader in rapid diagnostic testing
Biosynex announces that it has signed a binding offer to acquire 100% shares of the Avalun

© Copyright | All Rights Reserved | Biosynex®

Facebook LinkedIn YouTube

Toggle Sliding Bar Area

Laboratoire Biosynex

Recent

Biosynex acquires Avalun to become European leader in rapid diagnostic testing
May 27th, 2021
Biosynex announces that it has signed a binding offer to acquire 100% shares of the Avalun
April 15th, 2021
ICASA 2019 : Inside the Community Village
December 6th, 2019

test

test